title: Heart failure in 2010: one step forward, two steps back.
abstract: Patients with heart failure (HF) fall into two categories—those who are stable and ambulatory with a relatively low event rate, and patients requiring hospitalization who are characterized by high post-discharge mortality and rates of rehospitalization. HF trials in 2010 contributed to the advancement of outpatient management, whereas the development of novel therapies with a survival benefit remains an unmet need in acute HF syndromes.
authors.affiliation: Center for Cardiovascular Innovation, Feinberg School of Medicine, Northwestern University, 645 North Michigan Avenue, Chicago, IL 60611, USA. m-gheorghiade@northwestern.edu
authors.forename: Mihai
authors.initials: M
authors.lastname: Gheorghiade
authors.forename: Andrew
authors.initials: A
authors.lastname: Ambrosy
mesh_terms: D006333:Heart Failure / Q000188:drug therapy* / Q000401:mortality / Q000628:therapy; D006801:Humans; D016032:Randomized Controlled Trials as Topic